Stockscreener 앱 받기
34.08
2.34%
0.78
시간 외 거래:
35.10
1.02
+2.99%
Corcept Therapeutics Inc 주식(CORT)의 최신 뉴스
CORT INVESTOR ALERT: Contact Kirby McInerney LLP About - GlobeNewswire
CORT INVESTOR ALERT: Contact Kirby McInerney LLP About Securities Class Action Lawsuit On Behalf of Corcept Therapeutics Incorporated Investors - GlobeNewswire Inc.
Corcept Therapeutics (NASDAQ:CORT) Director Buys $3,314,000.00 in Stock - MarketBeat
Corcept Therapeutics (CORT) Director Purchases Significant Share Amount - GuruFocus
Corcept Therapeutics (CORT) director adds 100,000 shares in open-market buys - Stock Titan
Corcept therapeutics director Baker buys shares worth $3.3m By Investing.com - Investing.com Canada
Corcept Therapeutics Director Purchased Shares Worth Over $3.3M - TradingView
CORT SEC FilingsCorcept Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Deadline Alert: Corcept Therapeutics Incorporated (CORT) - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming DeadlinesCORT - PR Newswire
Zacks Research Has Pessimistic Outlook of CORT Q3 Earnings - MarketBeat
JPMorgan Chase & Co. Boosts Stock Position in Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept Therapeutics Shareholder Alert: ClaimsFiler Reminds - GlobeNewswire
Corcept Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Corcept Therapeutics Incorporated - GlobeNewswire Inc.
Robbins LLP Urges CORT Stockholders to Contact the Firm for Information About the Class Against Corcept Therapeutics Incorporated - PR Newswire
CORCEPT THERAPEUTICS INCORPORATED (CORT) - MSN
CORT Shareholder Notice: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss - ChartMill
Shareholders of Corcept Therapeutics Incorporated Should Contact Levi & Korsinsky Before April 21, 2026 to Discuss Your RightsCORT - Finviz
Corcept Therapeutics Inc (NASDAQ:CORT): A GARP Pick with Accelerating Growth and a Solid Financial Base - ChartMill
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - GlobeNewswire Inc.
CORT INVESTOR ALERT: Hagens Berman Alerts Corcept - GlobeNewswire
[Form 4] CORCEPT THERAPEUTICS INC Insider Trading Activity - Stock Titan
Corcept Therapeutics (CORT) director exercises 30K options and gifts shares - Stock Titan
ROSEN, A LEADING LAW FIRM, Encourages Corcept Therapeutics Incorporated to Secure Counsel ... - Bluefield Daily Telegraph
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming Deadlines – CORT - ChartMill
Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Bronstein, Gewirtz & Grossman LLC Urges Corcept - GlobeNewswire
CORT Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Corcept Therapeutics Incorporated Securities Lawsuit -- The Gross Law Firm - PR Newswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Corcept Therapeutics Incorporated Securities Fraud Class - GlobeNewswire
CORT ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss - PR Newswire
Turning Pain Into Purpose - Women's Health
Portnoy Law Firm Announces Class Action on Behalf of Corcept Therapeutics Incorporated Investors - GlobeNewswire
Shareholders who lost money in shares of Corcept - GlobeNewswire
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm – Company AnnouncementFT.com - Financial Times
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit - PR Newswire
CORT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Corcept Therapeutics Incorporated to Contact the Firm Today! - ACCESS Newswire
Corcept Therapeutics (CORT) Is Down 5.1% After FDA Relacorilant Rejection And Investor LawsuitsWhat's Changed - simplywall.st
Checkpoint Capital L.P. Has $32.61 Million Stake in Corcept Therapeutics Incorporated $CORT - MarketBeat
A Look At Corcept Therapeutics (CORT) Valuation After Mixed Q4 And 2025 Results With Stronger 2026 Outlook - simplywall.st
CORT ALERT: Hagens Berman Alerts Corcept Therapeutics - GlobeNewswire
CORT Shareholder Alert: Corcept Therapeutics Incorporated - GlobeNewswire
Connor Clark & Lunn Investment Management Ltd. Purchases 51,864 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
Capital Fund Management S.A. Has $13.33 Million Position in Corcept Therapeutics Incorporated $CORT - MarketBeat
CORT Stock Price, Quote & Chart | CORCEPT THERAPEUTICS INC (NASDAQ:CORT) - ChartMill
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Corcept Therapeutics Incorporated to Secure Counsel Before Important Deadline in Securities Class ActionCORT - ACCESS Newswire
Corcept Therapeutics (CORT) Litigation: Hagens Berman Alerts Corcept (CORT) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline - PR Newswire
Corcept Therapeutics Lawsuit: CORT Investors Face Losses After FDA Rejection and Alleged Misleading Statements - TipRanks
CORCEPT THERAPEUTICS INCORPORATED (CORT) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds ... - Bluefield Daily Telegraph
CORCEPT THERAPEUTICS INCORPORATED (CORT) SHAREHOLDER ALERT - GlobeNewswire
CORT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Corcept Therapeutics Incorporated Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Lawsuit filed for Investors who lost money with shares of Corcept Therapeutics Incorporated (NASDAQ: CORT) - openPR.com
ROSEN, A LEADING NATIONAL FIRM, Encourages Corcept Therapeutics Incorporated to Secure Counsel ... - Bluefield Daily Telegraph
H.C. Wainwright Cuts Corcept Therapeutics Incorporated (CORT) Price Target, Keeps Buy Rating - Yahoo Finance
Corcept Therapeutics Shareholders Are Encouraged to Contact Johnson Fistel for More Information About Potentially Recovering Their Losses - marketscreener.com
Corcept Therapeutics Shareholders Are Encouraged to Contact - GlobeNewswire
1.20%
0.06%
자본화:
|
볼륨(24시간):